about
Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometrySusceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey.Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility patternZygomycosis in Immunocompromised non-Haematological Patients.Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesEtest cannot be recommended for in vitro susceptibility testing of mucorales.Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazolePosaconazole treatment in Korea: single-center experience over 5 years.Profile of isavuconazole and its potential in the treatment of severe invasive fungal infectionsInteraction of Zygomycetes with innate immune cells reconsidered with respect to ecology, morphology, evolution and infection biology: a mini-review.Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.Invasive mold infections: virulence and pathogenesis of mucorales.Clinical experience in invasive fungal infections.Susceptibility profiles of amphotericin B and posaconazole against clinically relevant mucorales species under hypoxic conditions.Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase.Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.Mucormycosis in Children: Review and Recommendations for Management.
P2860
Q24604418-8F92C5B3-242C-4E9D-BC17-1A2C9AF15C3BQ34187936-DFD437B3-5332-4CC6-A681-CCC97C3B7355Q34433129-D0C1E609-36DE-401F-9E64-2B5C1310560CQ35010681-A7DBF0C9-D0D3-4473-AFEB-AAD5609AB5CBQ35076896-F516CB27-FA29-4FB2-B082-BF52A8331081Q35595623-D9D1B6EE-B445-4820-9911-F88740940135Q35668229-717E8A5D-058F-438A-BE5A-BEF9AB5BDE0FQ35942379-72BF710F-9393-4025-8362-565A796ECC60Q37094649-F4DE0752-CC79-44D7-B18C-46E6EA204267Q38159688-B1C08963-FB56-458B-9123-ABBCB6194DF9Q38250636-D57A965C-7947-4489-8034-61F62146D98AQ38430959-BCAA2C78-B0BE-4162-92CE-E36C00F77C99Q38909410-8E8BD883-8D1C-4C6E-AF97-48C980C1A14FQ40257954-8207EF5A-2E6C-427B-9ED0-1FC86BC9A332Q43156890-8FF405F2-A324-4778-AB0A-2A504B418529Q46256758-784F968C-7D5F-4032-BFC2-37E2ED6387EBQ46834709-9C4ADCA4-2007-4A12-AC68-3B50D42B302DQ47222680-3BB5D17F-BFEA-48EA-90F7-14619AC90295
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro activity of antifungals against Zygomycetes.
@en
In vitro activity of antifungals against Zygomycetes.
@nl
type
label
In vitro activity of antifungals against Zygomycetes.
@en
In vitro activity of antifungals against Zygomycetes.
@nl
prefLabel
In vitro activity of antifungals against Zygomycetes.
@en
In vitro activity of antifungals against Zygomycetes.
@nl
P2093
P50
P1476
In vitro activity of antifungals against Zygomycetes
@en
P2093
J L Rodríguez-Tudela
M V Castelli
P356
10.1111/J.1469-0691.2009.02984.X
P478
15 Suppl 5
P577
2009-10-01T00:00:00Z